(Q38051245)

27 August 2017

title

Clostridium difficile: Changing Epidemiology, Treatment and Infection Prevention Measures (English)

1 reference

27 August 2017

main subject

Clostridium difficile

0 references

1 reference

Jane A Cecil

1

1 reference

27 August 2017

publication date

1 December 2012

1 reference

Current infectious disease reports

27 August 2017

published in

1 reference

27 August 2017

volume

14

1 reference

27 August 2017

issue

6

1 reference

27 August 2017

page(s)

612-619

1 reference

INTESTINAL FLORA IN NEW-BORN INFANTS

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

Antibiotic-Associated Pseudomembranous Colitis Due to Toxin-Producing Clostridia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

Narrative review: the new epidemic of Clostridium difficile-associated enteric disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

Attributable outcomes of endemic Clostridium difficile-associated disease in nonsurgical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

Increase in Clostridium difficile-related mortality rates, United States, 1999-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

An epidemic, toxin gene-variant strain of Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

New trends in Clostridium difficile virulence and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

Molecular analysis of Clostridium difficile PCR ribotype 027 isolates from Eastern and Western Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

Complete restriction of fluoroquinolone use to control an outbreak of Clostridium difficile infection at a community hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

Binary toxin-producing, large clostridial toxin-negative Clostridium difficile strains are enterotoxic but do not cause disease in hamsters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

Clostridium difficile infections in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

Population-based surveillance of Clostridium difficile infection in Manitoba, Canada, by using interim surveillance definitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

Risk factors for and estimated incidence of community-associated Clostridium difficile infection, North Carolina, USA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

Optimum timing of blood tests for monitoring patients with Clostridium difficile-associated diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

Clinical risk factors for severe Clostridium difficile-associated disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

Clostridium difficile: progress and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

Clostridium difficile testing algorithms: what is practical and feasible?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

Lack of value of repeat stool testing for Clostridium difficile toxin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

Evaluation of the C.Diff Quik Chek Complete Assay, a new glutamate dehydrogenase and A/B toxin combination lateral flow assay for use in rapid, simple diagnosis of clostridium difficile disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

C. Diff Quik Chek complete enzyme immunoassay provides a reliable first-line method for detection of Clostridium difficile in stool specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

Comparison of a commercial real-time PCR assay for tcdB detection to a cell culture cytotoxicity assay and toxigenic culture for direct detection of toxin-producing Clostridium difficile in clinical samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

Diagnostic accuracy of real-time polymerase chain reaction in detection of Clostridium difficile in the stool samples of patients with suspected Clostridium difficile Infection: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

Treatment of Clostridium difficile-associated disease: old therapies and new strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

Emergency subtotal colectomy for fulminant Clostridium difficile colitis--is a surgical solution considered for all patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

A new macrocyclic antibiotic, fidaxomicin (OPT-80), causes less alteration to the bowel microbiota of Clostridium difficile-infected patients than does vancomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

Fidaxomicin preserves the intestinal microbiome during and after treatment of Clostridium difficile infection (CDI) and reduces both toxin reexpression and recurrence of CDI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

Fidaxomicin versus vancomycin for Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

Treatment of first recurrence of Clostridium difficile infection: fidaxomicin versus vancomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

Efficacy of fidaxomicin versus vancomycin as therapy for Clostridium difficile infection in individuals taking concomitant antibiotics for other concurrent infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

Clostridium difficile--more difficult than ever

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

Treatment with monoclonal antibodies against Clostridium difficile toxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

Toxin-binding treatment for Clostridium difficile: a review including reports of studies with tolevamer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

New approach to the management of Clostridium difficile infection: colonisation with non-toxigenic C. difficile during daily ampicillin or ceftriaxone administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

Persistence of skin contamination and environmental shedding of Clostridium difficile during and after treatment of C. difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

Blood pressure cuff as a potential vector of pathogenic microorganisms: a prospective study in a teaching hospital.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

Comparison of the effect of detergent versus hypochlorite cleaning on environmental contamination and incidence of Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

Successful use of feedback to improve antibiotic prescribing and reduce Clostridium difficile infection: a controlled interrupted time series

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0298-9

Clinical features of Clostridium difficile-associated diarrhoea due to binary toxin (actin-specific ADP-ribosyltransferase)-producing strains

21 January 2018

1 reference

12 December 2020

Clostridium difficile infection in Ohio hospitals and nursing homes during 2006

1 reference

12 December 2020

Comparison of the burdens of hospital-onset, healthcare facility-associated Clostridium difficile Infection and of healthcare-associated infection due to methicillin-resistant Staphylococcus aureus in community hospitals

1 reference

12 December 2020

Reduction in the incidence of Clostridium difficile-associated diarrhea in an acute care hospital and a skilled nursing facility following replacement of electronic thermometers with single-use disposables

1 reference

12 December 2020

Interruption of Recurrent Clostridium difficile-Associated Diarrhea Episodes by Serial Therapy with Vancomycin and Rifaximin

1 reference

12 December 2020

Environmental control to reduce transmission of Clostridium difficile

1 reference

12 December 2020

Strategies to prevent clostridium difficile infections in acute care hospitals

1 reference

12 December 2020

Detection of toxigenic Clostridium difficile in stool samples by real-time polymerase chain reaction for the diagnosis of C. difficile-associated diarrhea

1 reference

12 December 2020

Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters

1 reference

12 December 2020

Evaluation of stethoscopes as vectors of Clostridium difficile and methicillin-resistant Staphylococcus aureus

1 reference

12 December 2020

Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea

1 reference

12 December 2020

Short- and long-term attributable costs of Clostridium difficile-associated disease in nonsurgical inpatients

1 reference

12 December 2020

Severe Clostridium difficile-associated disease in populations previously at low risk--four states, 2005.

1 reference

12 December 2020

Decrease of hypervirulent Clostridium difficile PCR ribotype 027 in the Netherlands.

1 reference

12 December 2020

Clostridium difficile–associated diarrhea: an emerging threat to pregnant women

1 reference

12 December 2020

10.1007/S11908-012-0298-9

Identifiers

DOI

1 reference

27 August 2017

1 reference